New research could change the way health professionals treat Alzheimer’s disease, which affects more than 35.6 million people worldwide, a figure set to treble by 2050.
New treatments that combat the growing problem of antibiotic resistance by disarming rather than killing bacteria may be on the horizon, according to a new study.